Search Site close Close
News

DoD Grant Boosts ALS and Dementia Drug Discovery Pipeline

Published Date:

Carbondale lab to study genetics of disease

The viral “Ice Bucket Challenge” that encouraged participants to raise money and awareness for amyotrophic lateral sclerosis (ALS) research has funded studies that led to a recent breakthrough: discovery of a new target gene common in more than 1,000 families with a history of ALS.

Based on those findings, a scientist at Southern Illinois University School of Medicine in Carbondale has been awarded a two-year grant from the Department of Defense that will allow him to use cutting-edge technology to study a key genetic mutation that causes both ALS, or Lou Gehrig’s disease, as well as a common memory disorder called frontotemporal dementia (FTD). Keith Gagnon, PhD, assistant professor of biochemistry and molecular biologyDoD Grant Boosts ALS and Dementia Drug Discovery Pipeline, will be working in collaboration with the High Throughput Bioscience Center at Stanford University to screen more than 100,000 chemicals in search of potential ALS and FTD treatments.

The grant award is $648,728.

ALS is a progressive neurodegenerative disease that causes muscle weakness, paralysis and ultimately, respiratory failure. The new study will focus on the most common genetic form of ALS and FTD, which is caused by mutation in a gene called C9ORF72. Gagnon’s lab will develop models of disease based on special signatures from the C9ORF72 gene and track them at the cellular level with fluorescent imaging. The Stanford center will then use automation to rapidly “read” the biological activity of the models and screen them through chemical libraries in search of potential drug candidates that could ultimately improve patient outcomes. The project is funded by a Therapeutic Idea Award through the Department of Defense ALS Research Program.

Gagnon received his doctorate in biochemistry in 2007 from North Carolina State University. After completing postdoctoral training at UT Southwestern Medical Center in Dallas, Texas, he was jointly appointed to the Department of Chemistry and Biochemistry in the College of Science and the Department of Biochemistry and Molecular Biology in the School of Medicine in 2014.

Research reported in this press release is supported by US DoD under contract number W81XWH-16-1-0176.

 

 

                                                                                                ALS cell model screening                                                                                        

 

More from SIU News

801

SIU Medicine launches national search for next dean, provost and CEO

Southern Illinois University Medicine has launched a national search for its next dean, provost and CEO. The search will be conducted in partnership with Isaacson, Miller, a national executive search firm specializing in academic medicine and higher education leadership.
Ginger Meyer and Allison Jackson

Ginger Meyer honored for leadership in trauma recovery

Ginger Meyer has spent more than twenty years helping children and families in southern Illinois heal from trauma, and her steady leadership recently earned national recognition from the Academy on Violence and Abuse. As clinical director of SIU School of Medicine’s Children’s Medical and Mental Health Resource Network, she has expanded access to trauma-informed care across rural communities, supported partners who serve children affected by abuse and violence, and trained hundreds of graduate students in evidence-based treatment. Her service with AVA strengthened national efforts to integrate trauma-informed practices into health care, and colleagues praise her ability to unite teams, guide change and keep families at the center of the work. Through her leadership, more children across central and southern Illinois can find safety, support and hope close to home.
Moy Clinic Building in winter

AFSCME, SIU School of Medicine ink 3-year agreement

SIU School of Medicine and AFSCME Local 370 have finalized and ratified a new collective bargaining agreement, effective July 1, 2025, through June 30, 2028. The union represents more than 800 school employees across its campuses.